Related Experiment Video

Updated: Jun 11, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infection

Franco Maggiolo, Sebastiano Leone

    Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
    |July 6, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
    09:54

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

    Published on: December 3, 2019

    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
    09:26

    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

    Published on: October 15, 2013

    Related Experiment Videos

    Last Updated: Jun 11, 2026

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
    09:54

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

    Published on: December 3, 2019

    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
    09:26

    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

    Published on: October 15, 2013

    Related Concept Videos

    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency disorders...
    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

    Articles linked to this work by shared authors, journal, and citation graph.

    Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort.

    Open forum infectious diseases·2026

    Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy.

    Diseases (Basel, Switzerland)·2026

    96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: A retrospective cohort study.

    Journal of global antimicrobial resistance·2025

    The Clinical Impact of the Omicron Variant on Octogenarian Hospitalized COVID-19 Patients: The Results from CoviCamp Cohort.

    Biomedicines·2025

    Use of Daptomycin to Manage Severe MRSA Infections in Humans.

    Antibiotics (Basel, Switzerland)·2025

    Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection.

    AIDS (London, England)·2025

    Relationship between Antibiotic Prescription and Survival in Hospice.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    Use of Whole Genome Sequencing to Investigate the Risk for Transmission of Clostridioides difficile From Prior Room Occupants: A Single-Center Study.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    Histoplasma Capsulatum Antigen Persistence and Rate of Decay During Treatment of Histoplasmosis Varies by Immune Status.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    Reducing Empiric Vancomycin Use in the Pediatric Intensive Care Unit: a Multicenter Study.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    Characterizing measles healthcare facility exposures-December 2023-September 2025-New York City.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.

    Journal of human immunity·2026

    Gut microbiota functional remodeling and butyrate depletion amplify anti-Ro/La antibody-driven type I interferon activation in neonatal lupus.

    Gut microbes·2026

    Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.

    International reviews of immunology·2026

    Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.

    Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

    Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.

    Immunity, inflammation and disease·2026

    Inferior vena cava agenesis: Clinical presentation, imaging characteristics, and midterm outcomes with a proposed diagnostic algorithm.

    Phlebology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us